AMIORG Stock View

Ami Organics Ltd
stock-view-header

₹ 1,233.25

icon -12.80 | -1.03
Market Cap ₹( Cr.)
45,482.95
Proj. P/E (x)
41.55
Proj. P/BV (x)
6.48
Proj. ROE (%)
16.35
Proj EV / EBITDA (x)
--
Proj. Revenue ( Cr.)
7,693.17

Stock View

BUY

Last Updated On.
01-Oct-2023
 

The average score for Ami Organics Ltd stands at 5 against 7, three months back.

Ami Organics Limited is an India-based manufacturer of specialty chemicals with varied end usage, focus on the development and manufacturing of pharma intermediates for regulated and generic active pharmaceutical ingredient (APIs) and new chemical entity (NCEs). It manufactures pharma intermediates for certain APIs, including dolutegravir, trazodone, entacapone, nintedanib and rivaroxaban. The pharma intermediates, which the Company manufactures have application in certain high-growth therapeutic areas, including anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson, anti-depressant and anti-coagulant. It has developed and commercialized over 450 pharma intermediates for APIs and NCEs across 17 therapeutic areas. Its specialty chemicals have applications in the agrochemicals and fine chemicals industries. The Company supplies its products to more than 150 customers directly in India and to approximately 25 countries overseas.

Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.


Technical Data

50 DMA(₹)
1,257.26
100 DMA(₹)
1,237.11
200 DMA(₹)
1,090.77
52 Weeks Range
844.95     1,387.50

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required